BHI 3.0·Q1 2026 Bulletin
Last computed 14:32 UTC, Apr 29 2026·Spearman ρ = 0.83·Validation: preliminary
Today's bulletin →
Movers · since 14:32 UTC, Apr 29 2026
PLATFORM PROFILEMRNA

Moderna

$15BmRNA platformPharma & Biotech
1.86
B-index (V3.1)
EVENT HORIZON
Capture0.849
Escape0.456
Key Structural Insight

Platform-level lock-in for governments, not consumers. Pandemic preparedness infrastructure cannot switch vendors mid-crisis.

Eleven-Parameter Profile

5DATAMEMACTPROCNETCLOSEPORTSUBFALLORGMOM
Data Depth7/10
Memory7/10
Action7/10
Process6/10
Network6/10
Closeness5/10
Portability4/10
Substitutability5/10
Human Fallback5/10
Org Depth6/10
Momentum8/10
Capture Escape Extended

V3.1 Decomposition

ComponentValueFormula
CES₄ capture core0.6743CES(d, m, a, p)
Knowledge synergy σₖ0.7000√(d · m)
Operability synergy σₒ0.6481√(a · p)
Synergy boost1.20221 + 0.3·(σₖ + σₒ)/2
Org-depth multiplier1.30001 + 0.5·o
Momentum multiplier1.24001 + 0.3·t
Total Capture0.8494c·(1+0.5n)·core·syn·org·mom
CES₃ escape core0.4654CES(x, s, h)
Feedback attenuation0.7640max(0.3, 1 − 0.35·core)
Total Escape0.4556ε + escCore · feedback
B = Capture / Escape1.860.849 / 0.456

Scoring Rationale

mRNA platform technology. Sequence-to-vaccine in weeks. But platform lock-in is scientific, not commercial — competitors (BioNTech, CureVac) building parallel platforms. Real lock-in is for governments that have built pandemic response infrastructure around mRNA.

Parameter Sensitivity

MARGINAL B-INDEX CHANGE PER ±1 SCORE SHIFT
CLOSE5
+0.75
PORT4
-0.23
PROC6
+0.21
SUB5
-0.20
FALL5
-0.20
DATA7
+0.19
MEM7
+0.19
ACT7
+0.19
ORG6
+0.14
NET6
+0.14
MOM8
+0.09
+ raises B (deepens lock-in) lowers B (aids escape)

Comparable PlatformsPharma & Biotech (5 peers)

#PlatformTickerB-indexZone
01IlluminaILMN5.78BLACK HOLEProfile →
02IQVIAIQV5.18BLACK HOLEProfile →
03Thermo FisherTMO4.38BLACK HOLEProfile →
04RocheROG.SW3.88BLACK HOLEProfile →
05Veeva SystemsVEEV3.88BLACK HOLEProfile →